label: Introduction of Cytarabine and Daunorubicin Liposome Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 3
label_lc: introduction of cytarabine and daunorubicin liposome antineoplastic into peripheral vein, percutaneous approach, new technology group 3